We’d like to take a moment to thank our incredible sponsors for their contributions to our upcoming 9th Annual Stanford Drug Discovery Symposium! We are incredibly grateful for their partnership and support. Join them in making #SDDS2025 a forefront for drug research and email?[email protected]. Sponsorships must be confirmed by April 1, 2025. We’re looking forward to working with you! Alexandria Real Estate Equities, Inc., Medical Excellence Capital, LLC, Medable, Inc, Amgen, AbbVie, BioMarin Pharmaceutical Inc.,??BioRender, Cytokinetics, Gilead Sciences, Gooter-Jensen Foundation, Stanford Health Care, a16z Bio + Health,?Takeda,?Wilson Sonsini Goodrich & Rosati, WuXi AppTec,?ACROBiosystems, Alamar Biosciences, Inc.,?Ansa Biotechnologies, Inc.,?Biortus,?BridgeBio,?Collaborative Drug Discovery - CDD Vault, Curie.Bio,?Cytiva,?Greenstone Biosciences,?NUVISAN The Science CRO,?SPARK Finland,?SPARK Norway,?Stanford Research Park,?Vala Sciences,?Walden Catalyst Ventures
Stanford Cardiovascular Institute
医院和医疗保健
Stanford，California 2,172 位关注者
Devoted to research, education, and clinical applications that advance cardiovascular science
关于我们
In an era of constant change and innovations, the Cardiovascular Institute leverages the incredible intellectual manpower found within Stanford University. The Institute focuses its resources to: - Ignite new research and clinical applications by awarding seed grants - Establish educational and training programs in the field of cardiovascular medicine and research - Support activities outside the bench and clinic that facilitates exchange of ideas through seminar series and invited guests open to all members
- 网站
-
https://med.stanford.edu/cvi.html
Stanford Cardiovascular Institute的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 11-50 人
- 总部
- Stanford，California
- 类型
- 非营利机构
- 创立
- 2004
- 领域
- Cardiovascular Disease、Research和Education
地点
-
主要
获取路线
265 Campus Dr
G 1120
US，California，Stanford，94305
Stanford Cardiovascular Institute员工
-
Xiaozhi Gao, Ph.D.
Postdoctoral Research Fellow at Stanford Cardiovascular Institute
-
Souhrid Mukherjee
Computational Biologist | Data Scientist | ML Researcher Working in Industry | Drug Discovery | Precision Medicine
-
Yang Zhou
LSRP at Stanford Cardiovascular Institute
-
Adithan Kandasamy
Postdoctoral researcher in at Stanford Cardiovascular Institute
动态
-
Thank you for participating in our weekly Frontiers in Cardiovascular Science seminar. Next week we’re excited to have Dr. Sushma Reddy, MD?give her talk on “Microvascular Dysfunction in Congenital Heart Disease." Join us Tuesday, March 11th?at 12pm PST to hear her talk and visit?https://lnkd.in/g4qBJrUR?to learn more.
-
-
Thank?you for participating in our weekly?Frontiers in Cardiovascular Science seminar. This week we’re excited to have?Dr. Richard Gumina, MD, PhD?give his talk on “Impact of Ectonucleotidases on Cardiovascular Disease”. Join us Tuesday, March 4th?at 12pm PST to hear his talk and visit?https://lnkd.in/g4qBJrUR?to learn more.
-
-
Join us at the 9th Annual Stanford Drug Discovery Symposium on April 28-29, for 2 exciting days of talks and discussions, including our poster session. #SDDS2025 offers a unique opportunity for all members of the drug discovery community – including researchers, pharmaceutical companies, investment groups, academia, and the broader biomedical community – to share ideas and innovations.?Register now at?https://lnkd.in/gvqKZBzG! ?
-
Join us tonight for the CVI Early Career Happy Hour to hear James Zou on his Virtual Lab of AI Scientists concept on collaborative AI scientist agents conducting in silico research meetings to tackle open-ended, experimentally validated R&D projects. [Stanford only]
-
-
Thank you for participating in our weekly Frontiers in Cardiovascular Science seminar. Next week we’re excited to have Dr. Joe “Skip” G.N. Garcia give his talk on “DAMPening Inflammatory Injury and Fibrosis via Innate Immunity Targeting”. Join us Tuesday, February 25th?at 12pm PST to hear his talk and visit?https://lnkd.in/g4qBJrUR?to learn more.
-
-
How can we protect the heart while fighting cancer? A new study from?Han Zhu and other researchers at Stanford Cardiovascular Institute addresses this critical challenge, uncovering ways to protect cardiovascular health during cancer treatment. Their work,?recently published in Circulation Journal Research, uses a sophisticated combination of mouse models and heart biopsies from cancer patients to present a possible treatment to prevent and reverse heart damage from immune checkpoint inhibitors (ICIs). This research has important implications for patients, clinicians, and the future of cardio-oncology. https://lnkd.in/gFsPUEnm
-
A strong National Institutes of Health is critical for the future of biomedical research and innovation: https://lnkd.in/gQw8nwm5
At a critical time for scientific research, the new American Heart Association Presidential Advisory emphasizes medical and economic benefits of The National Institutes of Health funded research, offers principles to optimize the NIH’s role as the world’s preeminent medical research entity. https://lnkd.in/gXxN4Q5K As Congress and the administration reassess the funding, staffing and operations of the NIH, the Association offers five principles to optimize its future: 1) The U.S. should continue to prioritize high-quality biomedical research that is innovative and impactful. A coordinated strategy for prioritizing research questions and streamlining funding – involving patients and communities, researchers, clinicians, public health professionals and health and disease-specific organizations – could optimize productivity, effectiveness and impact. 2) The NIH should continue to improve efficiency and transparency in its peer review process. The Association believes the composition of review panels should continue to be multidisciplinary and recommends the NIH enhance peer-review discussions by having funded researchers fulfill a service responsibility to review grants. The NIH also should work to reduce the administrative burden for grant applications. 3) The NIH, in coordination with other federal agencies, should play a larger role in the translation of evidence into practice, including more funding for implementation research. The NIH would advance the translation of science into therapies by strengthening its partnerships with federal health agencies, health care and public health professionals, patients, health systems, payors, industry partners and community-based organizations. 4) The NIH should continue to build and support the biomedical research workforce with funding and training opportunities. The NIH must support researchers with different expertise and backgrounds throughout their careers. In addition, the U.S. should, must implement new, data-driven programs to help retain talented mid-career researchers, who can be tempted to leave academia for more competitive research funding and salaries. 5) Predictable, robust and sustained public investments in biomedical research should be a national priority. To compete with other countries and ensure a timely pipeline for groundbreaking discoveries, translation, clinical evaluation and implementation, the U.S. must make sustained public investment in biomedical research a national priority.
-
For next week’s Frontiers in Cardiovascular Science seminar, we’re excited to spotlight Dr. Christopher Gardener, PhD! Join us Tuesday, February 18th?at 12pm PST to hear his talk on “Communicating What to Eat - To Netflix or Not”. Visit?https://lnkd.in/g4qBJrUR?to learn more.
-
-
This year at #SDDS2025, we are thrilled to honor and celebrate the incredible contributions of our Lifetime Achievement Awardees and their groundbreaking work on #GLP-1 and the transformative impact on metabolic disease treatments: Jens Juul Holst, MD, DMSc Joel Habener, MD Lotte Bjerre Knudsen, DMSc Their dedication to scientific excellence opened new avenues in therapeutic developments. Join us in celebrating these exceptional leaders and their lifelong contributions to science! #SDDS2025 #LifetimeAchievement #DrugDiscovery
-